Home > Insider Trading > Filing (0001209191-19-049728)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1277462	Karen Gibson	12544 High Bluff Drive, Suite 200 San Diejo CA 92130	Svp, Is & Bus. Transformation	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-09-13	4,527	$67.52	759	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

On September 13, 2019, the reporting person filed a Form 4 which mistakenly reported that the price per share of the securities disposed of was $67,515.00. The correct price per share of the securities disposed was $67.515. The number of securities reported (4,527) did not change.
The weighted average sale price for these transactions was $67.515 per share, with a range of $67.285 to $67.845. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The amount of securities beneficially owned following this transaction include an additional 95 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.